Tyrosine kinase inhibitor effects on avian osteoclastic acid transport

American Journal of Clinical Nutrition

Volumn 68, Issue 6 SUPPL., 1998, Pages

  Williams, John P ^b   Jordan, S Elizabeth ^b   Barnes, Stephen ^b   Blair, Harry C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

Benzoquinone; Bone resorption; Genistein; Herbimycin; Osteoclast membrane; Osteoporosis; Soy products; Tyrosine kinase; Tyrphostins

Indexed keywords

ACRIDINE ORANGE; ADENOSINE TRIPHOSPHATE; BENZOQUINONE DERIVATIVE; CHLORIDE CHANNEL; CHLORIDE ION; DAIDZEIN; DIMETHYL SULFOXIDE; GENISTEIN; HERBIMYCIN; HYDROCHLORIC ACID; ISOFLAVONE DERIVATIVE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTON; SOYBEAN PROTEIN; TYRPHOSTIN; TYRPHOSTIN A1; TYRPHOSTIN A25; TYRPHOSTIN A47; UNCLASSIFIED DRUG; VALINOMYCIN;

ANIMAL CELL; CELL MEMBRANE TRANSPORT; CHLORIDE TRANSPORT; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEN; MEMBRANE VESICLE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTON TRANSPORT;

ANIMALIA; AVES; GLYCINE MAX;

EID: 0031795623     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.6.1369S     Document Type: Conference Paper

References (16)

1. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991;64:693-702.
2. c-src expression for osteoclasts to form ruffled borders and resorb bone. J Clin Invest 1992;90:1622-7.
3. Blair HC, Jordan SE, Peterson G, Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 1996;60:629-37.
4. c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. J Clin Invest 1993;91:2791-5.
5. Uehara Y, Fukazawa H. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. Methods Enzymol 1991;201:370-9.
6. Levitzki, A. Tyrphostins - potential antiproliferative agents and novel molecular tools. Biochem Pharmacol 1990;40:913-8.
7. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5.
8. Blair HC, Kahn AJ, Crouch EC, Jeffrey JJ, Teitelbaum SL. Isolated osteoclasts resorb the organic and inorganic components of bone. J Cell Biol 1986;102:1164-72.
9. +-ATPase of avian osteoclast ruffled membrane. Am J Physiol 1991;260:C1315-24.
10. Radding W, Williams JP, Hardy RW, et al. Calmodulin concentrated at the osteoclast ruffled border modulates acid secretion. J Cell Physiol 1994;160:17-28.
11. Van Epps-Fung C, Williams J, Cornwell T, et al. Regulation of osteoclastic bone resorption by cGMP-dependent protein kinase. Biochem Biophys Res Commun 1994;204:565-71.
12. Taher MM. Herbimycin A inhibits protein kinase C in vascular smooth muscle cells. Biochem Mol Biol Int 1996:39;167-77.
13. Agnusdei D, Camporeale A, Gonnelli S, Gennari C, Baroni MC, Passeri M. Short-term treatment of Paget's disease of bone with ipriflavone. Bone Miner 1992;19(suppl):S35-42.
14. Albanese CV, Cudd A, Argentino L, Zambonin-Zallone A, MacIntyre I. Ipriflavone directly inhibits osteoclastic activity. Biochem Biophys Res Commun 1994;199:930-6.
15. Mazzuoli G, Romagnoli E, Carnevale V, et al. Effects of ipriflavone on bone remodeling in primary hyperparathyroidism. Bone Miner 1992;19(suppl.):S27-33.
16. Tsuda M, Kitazaki T, Ito T, Fujita T. The effect of ipriflavone (TC-80) on bone resorption in tissue culture. J Bone Miner Res 1986;1:207-11.